p53 Vaccine for Ovarian Cancer

NCT00001827 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Ovarian Neoplasm

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: p53 peptide vaccine
BIOLOGICAL: sargramostim
BIOLOGICAL: therapeutic autologous dendritic cells
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation

Sponsor

National Cancer Institute (NCI)